Search clinical trials for: Brexpiprazole (OPC-34712)

Total 948 results

Nobelpharma

Completed

An Additional Study of NPC-22 in Healthy Adult Males

Safety and Pharmacokinetics

Japan
Nobelpharma

Completed

A Study of NPC-22 in Healthy Adult Males

Healthy Adult Subjects

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Atopic Dermatitis

Japan
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

Smoking Cessation

United States
University of Pennsylvania

Completed

Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach

Cancer of the Colon
University of Pennsylvania
National Institute on Aging (NIA)

Completed

Hepatocellular Carcinoma Surveillance in Cirrhotics

Hepatocellular Carcinoma | Cirrhosis

United States
Rigshospitalet, Denmark

Recruiting

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

COVID-19 | Influenza | RSV Infection

Denmark
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Withdrawn

Comparison of the Effectiveness of Brexpiprazole With That of Risperidone (TAILWIND)

Schizophrenia
University Hospital, Rouen

Unknown

Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study (HiFlow-Heart)

Chronic Heart Failure
First Affiliated Hospital of Harbin Medical University

Completed

Efficiency and Changes of Cytokines Expression in Tear After Intense Pulsed Light Treating Dry Eye Disease

Dry Eye Syndromes

China
University of Valencia

Recruiting

Effectiveness of an Endurance Exercise Programme Preceded by Ischaemic Preconditioning in Older People

Older People

Spain
ResMed

Completed

Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN)

Chronic Obstructive Pulmonary Disease

United States
Otsuka Beijing Research Institute

Recruiting

Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
University of Oklahoma
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes... and other collaborators

Completed

HIV Risk and Prevention in Women

HIV

United States, Russian Federation
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian... and other conditions

United States
University of Pennsylvania

Completed

Effect of OPC Factor on Energy Levels

Healthy

United States
International Centre for Diarrhoeal Disease Research...

Completed

Poliovirus Vaccine Trial in Bangladesh

Healthy Infants

Bangladesh
Otsuka Pharmaceutical Co., Ltd.

Completed

Late Phase 2 Study of OPC-12759 Ophthalmic Suspension

Dry Eye Syndromes

Japan
Kepler University Hospital

Completed

Prediction of Intrahospital Cardiac Arrest Outcomes (PREDIHCA)

Cardiac Arrest

Austria
Otsuka Pharmaceutical Co., Ltd.

Completed

Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Valo Health, Inc.

Withdrawn

Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) (RESTORE)

Myocardial Infarction
Peking University Third Hospital

Completed

Application of Index of Microcirculatory Resistance to Evaluate Myocardial Protection After Ischemic Adaptation

Acute Myocardial Infarction

China
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Tuberculosis, Pulmonary | Extensively Drug-Resistant Tuberculosis | Tuberculosis, Multidrug Resistant

Korea, Republic of, China, United States, Egypt, Estonia, Japan, Latvia, Peru, Philippines
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Study of OPC-12759 Ophthalmic Solution

Dry Eye Syndromes

Japan
Andrei Krassioukov
University of British Columbia; Coloplast A/S; Vancouver Coastal Health; International...

Completed

Time Needed to Perform Intermittent Catheterization in Adults With Spinal Cord Injuries

Spinal Cord Injuries | Neurogenic Lower Urinary Tract Dysfunction

Canada
University of Tromso
Norwegian Council for Mental Health; The Dam Foundation; Norwegian Directorate...

Active, not recruiting

Opp - a Universal Mental Health Promoting Mobile Application for Adolescents (Opp)

Mental Health Wellness 1

Norway
Assistance Publique Hopitaux De Marseille

Completed

Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging (OPM)

Epilepsy

France
Helsinki University Central Hospital

Completed

Decision-making - the Benefit of Bedside CRP Within Ambulance Care (Q-CRP)

Critical Illness
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
University of Pennsylvania

Completed

COVID-19 SAFE Enrollment (COVID SAFE)

Covid19

United States
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.; Shin Nippon Biomedical Laboratories, Ltd.

Terminated

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Nasopharyngeal Carcinoma

Singapore
Radboud University Medical Center

Completed

The Impact of Age and Fitness on Reperfusion Injury and Ischemic Preconditioning to Prevent This Injury

Cardiovascular Disease

Netherlands
Institut Paoli-Calmettes

Not yet recruiting

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment (E-SN@P PROJECT)

Breast Cancer | Colorectal Cancer | Lung Cancer

France
Optinose US Inc.

Recruiting

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Bilateral Nasal Polyposis

United States
Karolinska University Hospital
Istituto Ortopedico Rizzoli; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Recruiting

Swedish Multicenter Trial of Outpatient Prevention of Leg Clots (StopLegClots)

Venous Thromboembolism | Ankle Fractures | Achilles Tendon Rupture

Sweden
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden
University of Miami
Arthrex, Inc.

Completed

Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound

ACL Injury

United States
Lineage Cell Therapeutics, Inc.

Completed

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Cervical Spinal Cord Injury | Spine Injury | Spinal Cord Trauma

United States
Oppilan Pharma Ltd
Celerion

Completed

A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers

Healthy

United Kingdom
Hospital Universitario 12 de Octubre
Apices Soluciones S.L.; Otsuka Pharmaceutical Co., Ltd.; Vivia Biotech

Completed

Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia

Acute Myeloid Leukemia

Spain
Mathematica Policy Research, Inc.
Centers for Medicare and Medicaid Services

Enrolling by invitation

Evaluation of the Comprehensive Primary Care Plus (CPC+) Model

All Conditions
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia

Japan
Myrexis Inc.

Terminated

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Alzheimer's Disease

United States, Canada
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Recruiting

CNS10-NPC for the Treatment of RP

Retinitis Pigmentosa

United States
Scientific Laboratory Products, Ltd.

Completed

Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)

Sleep Apnea Syndrome

Israel
Assiut University

Not yet recruiting

Mandibular Dimensions as a Predictor of Age and Sex in a Sample of Upper Egypt Population by Using Panoramic Images and Cone Beam Computed Tomography

Mandibular Dimensions
Boston Children's Hospital
The Hospital for Sick Children; Yale University; CURE Children's Hospital, Uganda

Recruiting

Improving Infant Hydrocephalus Outcomes in Uganda

Hydrocephalus

Canada, United States, Uganda

Search clinical trials for: Brexpiprazole (OPC-34712)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations